These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32604426)

  • 21. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
    Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
    Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
    Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
    J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complexity of ABO in coronary heart disease.
    Carpeggiani C
    Lancet; 2011 Apr; 377(9776):1492-3; author reply 1493-4. PubMed ID: 21531265
    [No Abstract]   [Full Text] [Related]  

  • 24. The association of polymorphic variants, rs2267788, rs1333049 and rs2383207 with coronary artery disease, its severity and presentation in North Indian population.
    Kashyap S; Kumar S; Agarwal V; Misra DP; Rai MK; Kapoor A
    Gene; 2018 Mar; 648():89-96. PubMed ID: 29309886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction.
    van Setten J; Isgum I; Smolonska J; Ripke S; de Jong PA; Oudkerk M; de Koning H; Lammers JW; Zanen P; Groen HJ; Boezen HM; Postma DS; Wijmenga C; Viergever MA; Mali WP; de Bakker PI
    Atherosclerosis; 2013 Jun; 228(2):400-5. PubMed ID: 23561647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
    Williams FM; Carter AM; Hysi PG; Surdulescu G; Hodgkiss D; Soranzo N; Traylor M; Bevan S; Dichgans M; Rothwell PM; Sudlow C; Farrall M; Silander K; Kaunisto M; Wagner P; Saarela O; Kuulasmaa K; Virtamo J; Salomaa V; Amouyel P; Arveiler D; Ferrieres J; Wiklund PG; Ikram MA; Hofman A; Boncoraglio GB; Parati EA; Helgadottir A; Gretarsdottir S; Thorsteinsdottir U; Thorleifsson G; Stefansson K; Seshadri S; DeStefano A; Gschwendtner A; Psaty B; Longstreth W; Mitchell BD; Cheng YC; Clarke R; Ferrario M; Bis JC; Levi C; Attia J; Holliday EG; Scott RJ; Fornage M; Sharma P; Furie KL; Rosand J; Nalls M; Meschia J; Mosely TH; Evans A; Palotie A; Markus HS; Grant PJ; Spector TD; ; ; ; ;
    Ann Neurol; 2013 Jan; 73(1):16-31. PubMed ID: 23381943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease.
    Kolovou G; Yiannakouris N; Hatzivassiliou M; Malakos J; Daskalova D; Hatzigeorgiou G; Cariolou MA; Cokkinos DV
    Curr Med Res Opin; 2002; 18(3):118-24. PubMed ID: 12094820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction?
    Wong CW; Christen T; Pfenniger A; James RW; Kwak BR
    Atherosclerosis; 2007 Apr; 191(2):355-61. PubMed ID: 16677656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers.
    Larsen JB; Hvas AM
    Pol Arch Intern Med; 2021 Nov; 131(11):. PubMed ID: 34623063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
    Jóźwik-Plebanek K; Prejbisz A; Wypasek E; Pręgowska-Chwała B; Hanus K; Kaszuba AM; Januszewicz M; Bieleń P; Kabat M; Kruk M; Dobrowolski P; Klisiewicz A; Śliwiński P; Januszewicz A; Undas A
    J Hypertens; 2017 May; 35(5):1035-1043. PubMed ID: 28141659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
    Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
    Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery disease-associated genetic variants and biomarkers of inflammation.
    Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Ajjan R; Würtz M; Grove EL; Hvas AM; Jensen HK; Kristensen SD
    PLoS One; 2017; 12(7):e0180365. PubMed ID: 28686695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography.
    Patel RS; Sun YV; Hartiala J; Veledar E; Su S; Sher S; Liu YX; Rahman A; Patel R; Rab ST; Vaccarino V; Zafari AM; Samady H; Tang WH; Allayee H; Hazen SL; Quyyumi AA
    Circ Cardiovasc Genet; 2012 Aug; 5(4):441-9. PubMed ID: 22767652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis.
    Collet JP; Allali Y; Lesty C; Tanguy ML; Silvain J; Ankri A; Blanchet B; Dumaine R; Gianetti J; Payot L; Weisel JW; Montalescot G
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2567-73. PubMed ID: 16917107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A; Kolarz M; Kopeć G; Tracz W
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic architecture of coronary artery disease in the genome-wide era: implications for the emerging "golden dozen" loci.
    Girelli D; Martinelli N; Peyvandi F; Olivieri O
    Semin Thromb Hemost; 2009 Oct; 35(7):671-82. PubMed ID: 20013534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease.
    Kristiansen J; Grove EL; Sjúrðarson T; Mohr M; Kristensen SD; Hvas AM
    Thromb Res; 2024 Apr; 236():220-227. PubMed ID: 38484628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban.
    Janion-Sadowska A; Natorska J; Siudut J; Ząbczyk M; Stanisz A; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1739-1749. PubMed ID: 28771277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.